The study, co-senior authored by Alexander Ioannidis, a genetics and biomedical data science researcher at Stanford University, analyzed whole-genome sequencing data from 1,050 individuals across French Polynesia, 12 unpublished genomes from Rapa Nui, and genomic data from Native Hawaiians, Samoans, and Tongans from the NIH's All of Us Biobank. Using a machine learning tool called Gnomix, the team isolated genetic segments of Polynesian ancestry and applied an identity-by-descent method to link living descendants to common ancestors.
"What we uncover in this paper is where the native people of Hawaii had come from," Ioannidis said. "Hawaii is the only Polynesian island in the Northern Hemisphere, so it's a long way from everything." The researchers found the closest genetic ties between Hawaii and Rapa Nui, with Mangareva Island suggested as the ancestral launching point for both populations.
The study highlights the founder effect: as small groups sailed between islands on double-hulled catamarans carrying only dozens of people, successive bottlenecks reduced genomic diversity and increased the odds of harmful mutations. Three mutations were associated with autosomal recessive conditions: a variant of ADAMTSL4 linked to detached lens in the eye, a PDE6B variant causing progressive vision loss, and a FAN1 variant associated with kidney failure. The FAN1 variant was so rare it was absent from the gnomAD database, which includes more than 800,000 combined genomes and exomes.
Ioannidis noted that these populations lack genetic testing recommendations and insurance coverage for conditions not yet documented. "We don't have recommendations for genetic testing, and there's no reimbursement from insurance because these are conditions we don't even know about," he said. "This is a population that should be getting research resources and attention from geneticists even more urgently."
